Environmental risk assessment in the EU regulation of medicines for human use: an analysis of stakeholder perspectives on its current and future role.

MLA

Zinken, Jim F., et al. “Environmental Risk Assessment in the EU Regulation of Medicines for Human Use: An Analysis of Stakeholder Perspectives on Its Current and Future Role.” Drug Discovery Today, vol. 29, no. 12, Oct. 2024, p. 104213. EBSCOhost, https://doi.org/10.1016/j.drudis.2024.104213.

APA

Zinken, J. F., Pasmooij, A. M. G., Ederveen, A. G. H., Hoekman, J., & Bloem, L. T. (2024). Environmental risk assessment in the EU regulation of medicines for human use: an analysis of stakeholder perspectives on its current and future role. Drug Discovery Today, 29(12), 104213. https://doi.org/10.1016/j.drudis.2024.104213

Chicago

Zinken, Jim F, Anna M G Pasmooij, Antwan G H Ederveen, Jarno Hoekman, and Lourens T Bloem. 2024. “Environmental Risk Assessment in the EU Regulation of Medicines for Human Use: An Analysis of Stakeholder Perspectives on Its Current and Future Role.” Drug Discovery Today 29 (12): 104213. doi:10.1016/j.drudis.2024.104213.